tiprankstipranks
Cinclus Pharma Holding AB (SE:CINPHA)
:CINPHA
Sweden Market
CINPHA
Cinclus Pharma Holding AB
RESEARCH TOOLSreports
Want to see SE:CINPHA full AI Analyst Report?

Cinclus Pharma Holding AB (CINPHA) Stock News & Sentiment

2 Followers
Cinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
Premium
Company Announcements
Cinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
4d ago
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
Premium
Company Announcements
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
17d ago
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
Premium
Company Announcements
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
1M ago
Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
Premium
Company Announcements
Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
2M ago
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
Premium
Company Announcements
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
2M ago
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
Premium
Company Announcements
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
2M ago
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
Premium
Company Announcements
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
3M ago
More SE:CINPHA News >

CINPHA News on the Web

Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
TipRanks News
Neutral
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
TipRanks News
Bullish
Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
TipRanks News
Bullish
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
TipRanks News
Bullish
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
TipRanks News
Bullish
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
TipRanks News
Bullish
Cinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SE:CINPHA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:CINPHA’s Media Buzz Sentiment?
1 articles about SE:CINPHA were published this week. In an average week, 1 articles are published.
    What is SE:CINPHA’s weekly average amount of articles?
    In an average week, 1 articles about SE:CINPHA are published.
      What is SE:CINPHA’s News Sentiment?
      50% of articles about SE:CINPHA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week